前哨淋巴结阳性黑色素瘤患者肿瘤负荷与黑色素瘤特异性生存的关系
本研究纳入736例前哨淋巴结阳性黑色素瘤患者,中位随访59.0个月,评估前哨淋巴结最大转移灶直径对黑色素瘤特异性生存(MSS)的预后价值。单因素和多因素分析显示,最大转移灶直径(≤0.5 mm vs >0.5 mm及≤1 mm作为连续变量)是III期患者MSS的独立预后因素,0.5 mm截断值的AUC(0.617)略高于1 mm(0.599)。结论提示考虑前哨淋巴结肿瘤负荷可更精确判断III期患者预后,未来分期系统应纳入该参数,最佳截断值尚待确定但倾向低于1 mm。
要点
- 前哨淋巴结最大转移灶直径是III期黑色素瘤MSS的独立预后因素。
- ≤0.5 mm和≤1 mm截断值下低肿瘤负荷患者MSS显著优于高负荷者。
- 0.5 mm截断值的AUC(0.617)略高于1 mm(0.599),倾向选择低于1 mm的截断值。
核心结论
- 考虑前哨淋巴结肿瘤负荷可在现有AJCC III期亚组内更精确判断黑色素瘤患者预后。
- 前哨淋巴结最大转移灶直径是III期患者MSS的独立预后参数,建议纳入未来分期系统。
- 最佳截断值尚未确定,但结果提示低于1 mm的截断值更可取。
研究设计与样本
- 回顾性分析736例前哨淋巴结阳性黑色素瘤患者,平均随访64.4个月,中位随访59.0个月。
- 前哨淋巴结肿瘤负荷以最大转移灶的最大直径评估。
- 采用Kaplan-Meier单因素分析和Cox多因素分析评估预后价值,并以ROC曲线比较不同截断值。
主要发现
- 单因素分析显示,IIIA、IIIB和IIIC期患者中前哨淋巴结肿瘤负荷较低(截断值≤0.5 mm和≤1 mm)者MSS显著优于负荷较高(>0.5 mm和>1 mm)者。
- 多因素Cox分析显示,最大转移灶直径(≤0.5 mm vs >0.5 mm及≤1 mm作为连续变量)是III期患者MSS的独立预后参数。
- 0.5 mm截断值的ROC曲线下面积(AUC=0.617)略高于1 mm截断值(AUC=0.599)。
关键数值与推荐
- 前哨淋巴结肿瘤负荷评估采用最大转移灶的最大直径,截断值包括≤0.5 mm vs >0.5 mm及≤1 mm(作为连续变量)。
- 0.5 mm截断值AUC为0.617,1 mm截断值AUC为0.599。
临床怎么用
- 对前哨淋巴结阳性黑色素瘤患者,应报告前哨淋巴结最大转移灶直径以辅助预后评估和患者咨询。
- 在现有AJCC III期亚组内,可结合前哨淋巴结肿瘤负荷更精细地判断预后。
- 临床咨询时可参考前哨淋巴结肿瘤负荷,但最佳截断值尚未确立,倾向使用低于1 mm的截断值。
局限性
- 前哨淋巴结肿瘤负荷的最佳截断值尚未确定。
- 本研究为单中心回顾性分析,结论需外部验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The tumor burden within the sentinel lymph node (SLN) is not included in the 8th edition of the American Joint Committee of Cancer (AJCC) melanoma classification. Therefore, we analysed the prognostic relevance of the SLN tumor burden in the stage III subgroups. PATIENTS AND METHODS: A total of 736 patients with melanoma with positive SLN and long-term follow-up (mean, 64.4 months; median, 59.0 months) were assessed. SLN tumor burden was evaluated by the maximum diameter of the largest deposit in all patients. RESULTS: By univariate Kaplan-Meier analyses, melanoma-specific survival (MSS) of patients in stage IIIA, IIIB and IIIC and lower sentinel tumor burden (cut-offs ≤0.5 mm and ≤1 mm) was significantly better than that in patients with higher sentinel tumor load (>0.5 mm and >1 mm). By multivariate analysis using the Cox model, the maximum diameter of the largest deposit (cut-off ≤0.5 mm versus >0.5 mm and cut-off ≤1 mm as continuous variables) represented an independent prognostic parameter for MSS in stage III patients. Cut-off of 0.5 mm showed a slightly higher area under the receiver operating characteristic curve (AUC = 0.617) when than the cut-off of 1 mm (AUC = 0.599). CONCLUSION: The prognosis of patients with stage III melanoma can be determined more precisely if the SLN tumor burden is considered, also within the existing AJCC subgroups. Thus, this parameter should be included in future classifications, and our study provides benchmarks in estimating prognosis and counselling patients with melanoma with positive sentinel nodes beyond the 8th AJCC Cancer Staging Manual. The optimal cut-off remains for SLN tumor burden remains to be determined, but our results suggest that a cut-off lower than 1 mm is preferable.
引用
- Satzger I, Leiter U, Gräger N, et al. Melanoma-specific survival in patients with positive sentinel lymph nodes: Relevance of sentinel tumor burden. Eur J Cancer. 2019. PMID: 31677550. doi:10.1016/j.ejca.2019.07.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。